Article Figures & Data
Additional Files
Data Supplement
- Supplemental_81935.pdf -
Supplemental Table 1 - Characteristics of cohort A (n=50)
Supplemental Table 2 - Correlation between midazolam oral clearance and selected tacrolimus pharmacokinetic parameters in cohort A
Supplemental Table 3 - Independent predictors of tacrolimus metabolite/parent ratios in cohort A
Supplemental Table 4 - Characteristics of cohort B (healthy volunteers)
Supplemental Table 5 - Tacrolimus metabolite/parent ratios in cohort B (healthy volunteers) before and after itraconazole, stratified by CYP3A5 genotype
Supplemental Table 6 - aasCharacteristics of cohort C. BMI
Supplemental Table 7 - Pharmacokinetic parameters of tacrolimus and its primary metabolites before and during CYP3A4 inhibition in cohorts B and C
- Supplemental_81935.pdf -